Type 2 Diabetes Mellitus Clinical Trial
— CHAT-POfficial title:
Validation of a CREATION Health Assessment Tool for Patients (CHAT-P) in a Diabetic Outpatient Population
NCT number | NCT03686917 |
Other study ID # | 1304646 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | October 1, 2018 |
Est. completion date | October 31, 2019 |
Verified date | March 2020 |
Source | Florida Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Participants will complete a survey before an educational session, during the "break" of an educational session, or after the session.
Status | Completed |
Enrollment | 260 |
Est. completion date | October 31, 2019 |
Est. primary completion date | September 1, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 120 Years |
Eligibility |
Inclusion Criteria: 1. Age 18 and above 2. Diagnosis of type II diabetes 3. Able to speak and understand English 4. Able to provide informed consent Exclusion Criteria: 1. Children under 18 2. Does not speak or understand English 3. Not of cognitive capacity to provide valid responses 4. Prisoners |
Country | Name | City | State |
---|---|---|---|
United States | Center for Whole-Person Research | Orlando | Florida |
Lead Sponsor | Collaborator |
---|---|
Florida Hospital |
United States,
Billioux, A., Verlander, K., Anthony, S., & Alley, D. (2017). Standardized screening for health-related social needs in clinical settings: The accountable health communities screening tool. Discussion Paper, National Academy of Medicine, Washington, DC. Retrieved from https://nam.edu/wp-content/uploads/2017/05/ Standardized-Screening-for-Health-Related-Social-Needsin-Clinical-Settings.pdf.
Cummings, D., Reed, M., & Chobotar, T. (2015). Creation Health Discovery: Live Life to The Fullest (5th ed.). Maitland, FL: Florida Hospital Publishing.
Polit, D. F. (2009) Data analysis & statistics for nursing research (2nd ed.). Upper Saddle River, NJ: Prentice Hall.
Roozen HG, Wiersema H, Strietman M, Feij JA, Lewinsohn PM, Meyers RJ, Koks M, Vingerhoets JJ. Development and psychometric evaluation of the pleasant activities list. Am J Addict. 2008 Sep-Oct;17(5):422-35. doi: 10.1080/10550490802268678. — View Citation
Stevens, J. (2002). Applied multivariate statistics for the social sciences (4th ed.). Mahwah, NJ: Lawrence Erlbaum Associates
van Bokhorst-de van der Schueren MA, Guaitoli PR, Jansma EP, de Vet HC. Nutrition screening tools: does one size fit all? A systematic review of screening tools for the hospital setting. Clin Nutr. 2014 Feb;33(1):39-58. doi: 10.1016/j.clnu.2013.04.008. Epub 2013 Apr 19. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | CHAT-P Score | Total score of 28 item survey. Survey scored using a 5-point scale: Strongly disagree, Disagree, Neutral, Agree, Strongly Agree | Survey administered one time at baseline during the single study visit. | |
Secondary | Demographics | Self reported demographics, including age, gender, and race | Collected one time at baseline during the single study visit. | |
Secondary | Adventist Wholeness Screening | 4 item survey. Q1 is YES/NO. Q2-4 are Yes/No/Not Sure | Collected one time at baseline during the single study visit. | |
Secondary | Personal Wellbeing Index | 9 items. Items are scored over an 11-point satisfaction scale with two response anchors of No Satisfaction at All / Completely Satisfied. | Collected one time at baseline during the single study visit. | |
Secondary | Multicultural Quality of Life Index | 10 items, answers on a scale of 1-10, with one being "Poor" and 10 being "Excellent". | Collected one time at baseline during the single study visit. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02771093 -
An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus
|
Phase 4 | |
Completed |
NCT02545842 -
Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL)
|
Phase 4 | |
Recruiting |
NCT03436212 -
Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump.
|
N/A | |
Completed |
NCT03244800 -
A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
|
Phase 2 | |
Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
Withdrawn |
NCT02769091 -
A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes
|
Phase 2 | |
Recruiting |
NCT06065540 -
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
|
Phase 3 | |
Recruiting |
NCT05008276 -
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
|
||
Completed |
NCT04091373 -
A Study Investigating the Pharmacokinetics of a Single Dose Administration of Cotadutide
|
Phase 1 | |
Completed |
NCT03296800 -
Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT06212778 -
Relationship Between Nutritional Status, Hand Grip Strength, and Fatigue in Hospitalized Older Adults With Type 2 Diabetes Mellitus.
|
||
Completed |
NCT05979519 -
Fresh Carts for Mom's to Improve Food Security and Glucose Management
|
N/A | |
Recruiting |
NCT05579314 -
XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
Terminated |
NCT03684642 -
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
|
Phase 3 | |
Completed |
NCT03248401 -
Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
|
Phase 4 | |
Completed |
NCT03644134 -
A Personalized Intervention to Manage Physiological Stress and Improve Sleep Patterns
|
N/A | |
Completed |
NCT05295160 -
Fasting-Associated Immune-metabolic Remission of Diabetes
|
N/A | |
Completed |
NCT02836873 -
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
|
Phase 3 | |
Completed |
NCT02226003 -
Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017)
|
Phase 3 |